Warning letter
Tomita Pharmaceutical Co., Ltd: warning letter of Jan 14, 2008
FDA warning letter UCM1048433 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM1048433 |
|---|---|
| Company | Tomita Pharmaceutical Co., Ltd |
| Subject | CGMP/Active Pharmaceutical Ingredients/Adulterated |
| Issue date | Jan 14, 2008 |
| Posted date | Jan 14, 2008 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Naruto |
| Inspection start date | Jul 31, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: